Co-Chairs:

Lindsey Kent

Assistant General Patent Counsel
Eli Lilly

Alexandra Moulson

Head Strategy, Portfolio and Program Management
PolPharma Biologics

Speakers:

Dominic Adair

Partner
Bristow LLP

Eran Bareket

Senior Partner, Head of Legal Practice
Gilat, Bareket & Co., Reinhold Cohn Group

Dr. Christof Bull

Associate General Patent Counsel
UCB Biopharma

Brian Coggio

Of Counsel
Fish & Richardson

Nicola Dagg

Partner
Kirkland & Ellis

Robin Ellis

Partner
Reddie & Grose (Former Head of IP Strategy at Sandoz)

Dr. Marc Gabriel, LL.M.

Partner
Baker McKenzie

David Jauch

Director Government Relations
Fresenius Kabi

Michael W. Johnson

Partner
Willkie Farr & Gallagher LLP

David Lancaster

Legal Director
Pinsent Mason

Claudia Louati

Policy Advisor
U.S. Food and Drug Administration

Marie Manley

Partner, Head of UK Life Sciences Practice
Sidley Austin

Alexander Meier

Partner
Preu Bohlig & Partner
(Former Global Head Legal & Pharma Drug Development at Novartis)

Lisa L. Mueller

Partner
Casimir Jones, S.C

Neha Pant

Director Program Management
Formycon AG

Keum Nang Park

Partner, Co-Head of Healthcare /Life Sciences Practice Group
Lee&Ko

Nicolas Pourbaix

Legal Director
Amgen

Heather M. Schneider

Partner
Willkie Farr & Gallagher LLP

Dean Thomas

Senior Director IP for Innovative Medicines and Biosimilars
Glenmark Pharmaceuticals

Alexandra Valenti

Partner
Goodwin

Christoph Volpers

Senior Patent Counsel
Michalski Hüttermann & Partner
(Former head of IP Biologics, Teva)

Oliver Werner

Head of SPC Working Group
German Patent and Trade Mark Office

Laura Whiting

Counsel
Freshfields Bruckhaus Deringer

Ha Kung Wong

Partner
Venable (Advisory Board Member at Center for Biosimilars)